Literature DB >> 27179609

miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B.

Li Zhang1, Daxiong Zeng2, Ying Chen3, Ning Li3, Yantian Lv3, Yong Li3, Xiao Xu4, Guopeng Xu5.   

Abstract

Lung cancer is the leading cause of cancer death worldwide, microRNAs play critical role in the initiation and development of lung cancer. Here, we used MTT assay, colony formation assay, soft agar growth assay and BrdU incorporation assay to investigate miR-937's role in lung cancer. We found that miR-937 was upregulated in lung cancer tissues and cells. Overexpression of miR-937 in A549 promoted anchorage -dependent and -independent growth, whereas knockdown of miR-937 reduced this effect. Meanwhile, we also found miR-937 overexpression increased CCND1 and c-Myc levels in both mRNA and protein levels, knockdown of miR-937 reduced this effect, confirming miR-937 promoted cell proliferation. Mechanism analyses found polyphosphate 4-phosphatase type II (INPP4B) was the target of miR-937, miR-937 directly bound to the 3'UTR of INPP4B, knockdown of INPP4B in A549 with miR-937 inhibitor promoted anchorage -dependent and -independent growth, suggesting miR-937 contributed to cell proliferation of lung cancer by inhibiting INPP4B, it might be a valuable target for lung cancer therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell proliferation; INPP4B; Lung cancer; miR-935

Mesh:

Substances:

Year:  2016        PMID: 27179609     DOI: 10.1016/j.lfs.2016.05.014

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  miR-4326 promotes lung cancer cell proliferation through targeting tumor suppressor APC2.

Authors:  Guopeng Xu; Zhongwei Zhang; Li Zhang; Ying Chen; Ning Li; Yantian Lv; Yong Li; Xiao Xu
Journal:  Mol Cell Biochem       Date:  2017-11-03       Impact factor: 3.396

2.  In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5- trans-docosenoate Isolated from Anchusa arvensis (L.) M.Bieb. Against HepG-2 Cancer Cells.

Authors:  Sajid Hussain; Farhat Ullah; Muhammad Ayaz; Syed Adnan Ali Shah; Azhar-Ul-Haq Ali Shah; Syed Majid Shah; Abdul Wadood; Waqar Aman; Riaz Ullah; Abdelaaty A Shahat; Fahd A Nasr
Journal:  Drug Des Devel Ther       Date:  2019-12-10       Impact factor: 4.162

3.  MicroRNA-937 inhibits the malignant phenotypes of breast cancer by directly targeting and downregulating forkhead box Q1.

Authors:  Xiaoting Han; Xiaolong Guo; Wenzhen Zhang; Qiumei Cong
Journal:  Onco Targets Ther       Date:  2019-06-20       Impact factor: 4.147

4.  Identification and Characterization of MicroRNAs Associated with Somatic Copy Number Alterations in Cancer.

Authors:  Jihee Soh; Hyejin Cho; Chan-Hun Choi; Hyunju Lee
Journal:  Cancers (Basel)       Date:  2018-11-29       Impact factor: 6.639

5.  INPP4B promotes colorectal cancer cell proliferation by activating mTORC1 signaling and cap-dependent translation.

Authors:  Xin-Hua Ruan; Xi-Mei Liu; Zhi-Xiang Yang; Shao-Peng Zhang; Quan-Zheng Li; Chun-Sheng Lin
Journal:  Onco Targets Ther       Date:  2019-04-23       Impact factor: 4.147

6.  miR-937 regulates the proliferation and apoptosis via targeting APAF1 in breast cancer.

Authors:  Huiying Fang; Wei Jiang; Zhouhong Jing; Xiaosong Mu; Zhongxun Xiong
Journal:  Onco Targets Ther       Date:  2019-07-17       Impact factor: 4.147

7.  Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.

Authors:  Emily Marie Mangialardi; Keyue Chen; Brittany Salmon; Jean Vacher; Leonardo Salmena
Journal:  Oncotarget       Date:  2019-10-29

8.  Oncogenic Role and Prognostic Value of MicroRNA-937-3p in Patients with Breast Cancer.

Authors:  Deyu Li; Jiangming Zhong; Guifeng Zhang; Li Lin; Zhenhua Liu
Journal:  Onco Targets Ther       Date:  2019-12-13       Impact factor: 4.147

9.  MicroRNA-937 is overexpressed and predicts poor prognosis in patients with colon cancer.

Authors:  Huiya Liu; Lin Ma; Ling Wang; Yizuo Yang
Journal:  Diagn Pathol       Date:  2019-12-19       Impact factor: 2.644

10.  SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.

Authors:  Irakli Dzneladze; John F Woolley; Carla Rossell; Youqi Han; Ayesha Rashid; Michael Jain; Jüri Reimand; Mark D Minden; Leonardo Salmena
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.